phidea
ai-native · crm-distribution · insurance

Zelros

AI platform for insurance distribution — recommending the right product to the right customer at the agent's or bancassurance teller's point of sale. 15 named European carriers and bancassurance partners in production, headquartered in Paris.

www.zelros.com ↗

Score

13/20
65%
Traction (named carrier deployments)
7 carrier deployment(s) with public source.
3/5
Maturity (years since founding)
10 years since founding (2016).
4/5
Coverage (insurance lines supported)
4 line(s) supported: auto, home, life, health.
4/5
Analyst recognition (Celent / Gartner / Forrester / Everest / ISG)
2 mention(s).
2/5

What it does

Zelros is an AI-native platform for insurance distribution and point-of-sale product recommendation. Founded 2016 in Paris by Christophe Bourguignat, Fabien Vauchelles, and Damien Philippon. The product sits on the agent's desktop or inside a bancassurance teller's system, matching customer profile to the right policy option and guiding the quote-and-bind conversation.

Named customer base. Seven named European carriers and bancassurance partners in production: AXA, BPCE, Crédit Agricole, MAIF, La Banque Postale, AssurOne, +Simple. Zelros reports 15 leading European providers in total. The US footprint is newer — the 2021 Series A was specifically framed as a vehicle to bring the platform to North America.

Funding. $16.5M total: seed + $11M Series A led by Silicon Valley-based BGV in February 2021, with ISAI, Plug and Play, HI INOV, 42CAP, and astorya.vc participating.

Where it sits in old → new → AI. The legacy rung is an agent's memory of the tariff binder. The modern rung is notable by its absence — carriers tended to buy distribution functionality as a feature inside the agent portal or the bancassurance core, and no dominant pure-SaaS modern vendor consolidated the category. Zelros is the AI-native entrant in a layer where the transition from legacy to AI-native was mostly direct.

Named deployments

Covers which actions

Last verified 2026-04-21.